Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.

Literature DB >> 4143056

Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.

W Stühlinger, O Kourilsky, A Kanfer, J D Sraer.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1974 PMID： 4143056 DOI： 10.1016/s0140-6736(74)90991-x

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Oliguric thrombotic microangiopathy during the fifth month of pregnancy.

Authors: A Vandewalle; A Kanfer; O Kourilsky
Journal: Br Med J Date: 1975-05-31

2. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors: Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal: Blood Date: 2006-04-18 Impact factor: 22.113

3. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.

Authors: Raffaella Rossio; Luca Andrea Lotta; Silvia Pontiggia; Nicolò Ghiringhelli Borsa; Isabella Garagiola; Gianluigi Ardissino; Danijela Mikovic; Massimo Cugno; Flora Peyvandi
Journal: Haematologica Date: 2014-11-07 Impact factor: 9.941

Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.

1. Oliguric thrombotic microangiopathy during the fifth month of pregnancy.

2. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

3. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.

Review 4. Complement System: a Neglected Pathway in Immunotherapy.

5. Recurrent haemolytic-uraemic syndrome with hypocomplementaemia: a case report.

Review 6. [Clinical aspects of the hemolytic-uremic syndrome].

7. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.

8. Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

9. Hemolytic-uremic syndrome.

10. Diagnosis and management of atypical hemolytic uremic syndrome in children: single centre experience.